Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2015 Nov;29(6):949-60.
doi: 10.1037/neu0000199. Epub 2015 May 25.

Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease

Collaborators, Affiliations
Observational Study

Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease

Ji-in Kim et al. Neuropsychology. 2015 Nov.

Abstract

Objective: Although Huntington disease (HD) is caused by an autosomal dominant mutation, its phenotypic presentation differs widely. Variability in clinical phenotypes of HD may reflect the existence of disease subtypes. This hypothesis was tested in prodromal participants from the longitudinal Neurobiological Predictors of Huntington Disease (PREDICT-HD) study.

Method: We performed clustering using longitudinal data assessing motor, cognitive, and depression symptoms. Using data from 521 participants with 2,716 data points, we fit growth mixture models (GMM) that identify groups based on multivariate trajectories.

Results: In various GMM, different phases of disease progression were partitioned by progression trajectories of motor and cognitive signs, and by overall level of depression symptoms. More progressed motor signs were accompanied by more progressed cognitive signs, but not always by higher levels of depressive symptoms. In several models, there were at least 2 groups with similar trajectories for motor and cognitive signs that showed different levels for depression symptoms-one with a very low level of depression and the other with a higher level of depression.

Conclusions: Findings indicate that at least intermediate HD progression might be associated with different levels of depression. Depression is one of the few symptoms that is treatable in HD and has implications for clinical care. Identification of potential depression subtypes may also help to select appropriate patients for clinical trials.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Motor, cognitive, and depressive signs and symptoms in people with prodromal HD measured by total motor score (TMS), symbol digit (SDMT), and Beck Depression Inventory (BDI). Each row shows two to six group trajectories for each outcome. Each panel shows variability of individual trajectories (grey) around the group mean trajectory (blue) by group for each outcome. Grp = group.

References

    1. Anderson MJ, Miyasaki JM. Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2012;79:597–603. - PMC - PubMed
    1. Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Hayden MR. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genetics. 1993;4:398–403. - PubMed
    1. Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Weintraub D. Pramipexole for the treatment of depressive signs in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurology. 2010;9:573–580. - PubMed
    1. Beck AT, Steer RA, Brown GW. Beck Depression Inventory-II Manual. The Psychological Corporation; NY: 1996.
    1. Biglan KM, Zhang Y, Long JD, Geschwind M, Kang GA, Killoran A, The PREDICT-HD Investigators of the Huntington Study Group Refining the diagnosis of Huntington disease: the PREDICT-HD study. Frontiers in Aging Neuroscience. 2013;5:12. - PMC - PubMed

Publication types